Daniel O'Day

PhRMA, navigating turbulence, taps Gilead CEO to helm board of directors
Fierce Pharma
Wed, 02/21/24 - 10:43 pm
PhRMA
lobbying
Daniel O'Day
Gilead Sciences
CEO Dan O'Day, tasked with boosting Gilead's oncology presence, scores $19M for a year focused on COVID
Fierce Pharma
Mon, 04/5/21 - 10:18 pm
Gilead Sciences
Daniel O'Day
executive pay
Pharma CEOs
Gilead's New CEO Is Going All-In on Acquisitions
Motley Fool
Sun, 11/29/20 - 02:23 pm
Gilead Sciences
M&A
Daniel O'Day
Pharma CEOs
Entire Stockpile Of Coronavirus Treatment Remdesivir Donated To Government, Says CEO
Forbes
Sun, 05/3/20 - 08:10 pm
Gilead Sciences
remdesivir
Daniel O'Day
pandemic
COVID-19
federal government
Gilead CEO: We’re going to make sure that access is not an issue with remdesivir
Stat
Wed, 04/29/20 - 10:54 pm
Gilead Sciences
Daniel O'Day
Pharma CEOs
remdesivir
COVID-19
pandemic
access
Gilead CEO O'Day feels 'sense of urgency' on dealmaking as Kite writedowns add up
Fierce Pharma
Wed, 02/5/20 - 10:13 pm
Gilead Sciences
Kite Pharma
Daniel O'Day
Pharma CEOs
Gilead CEO Daniel O'Day says company is in an 'acquisitive mode'
Stat
Wed, 11/20/19 - 10:43 pm
Gilead Sciences
Daniel O'Day
Pharma CEOs
M&A
4 Key Questions for Gilead Sciences' New CEO
Motley Fool
Wed, 09/11/19 - 09:48 am
Gilead Sciences
Daniel O'Day
Pharma CEOs
Gilead looks to Galapagos deal to double research capacity
Fierce Biotech
Wed, 07/31/19 - 10:20 am
Gilead Sciences
Daniel O'Day
Galapagos
R&D
Gilead's exec search won't hurt its deal search: CEO
Fierce Pharma
Wed, 07/31/19 - 08:46 am
Gilead Sciences
M&A
Daniel O'Day
Is Gilead Sciences Worth the Wait?
Motley Fool
Mon, 06/10/19 - 09:22 am
Gilead Sciences
Daniel O'Day
5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm
Motley Fool
Sun, 05/5/19 - 10:34 am
Gilead Sciences
Daniel O'Day
M&A
Kite Pharma
filgotinib
Gilead's first move under new chief is to untether Kite
Biopharma Dive
Fri, 05/3/19 - 10:47 pm
Kite Pharma
Gilead Sciences
CAR-T
Daniel O'Day
Gilead executives predict patience—and some deal scouting—from new CEO Daniel O'Day
Fierce Pharma
Tue, 02/5/19 - 10:00 am
Gilead Sciences
Daniel O'Day
M&A
Pharma CEOs
7 Things to Expect for Gilead Sciences in 2019
Motley Fool
Tue, 01/8/19 - 09:12 am
Gilead Sciences
JPMHC 2019
HIV
hepatitis C
M&A
Daniel O'Day
Gilead Taps Roche Veteran Daniel O’Day as New CEO
BioSpace
Mon, 12/10/18 - 11:58 am
Gilead Sciences
Pharma CEOs
Roche
Daniel O'Day
Pharma chief casts doubt on Roche interest in Alexion
Fierce Pharma
Thu, 09/12/13 - 10:30 am
Alexion
Roche
M&A
Daniel O'Day